Code | 3789E |
MA number | EU/1/23/1740/001 |
Product Form: | plv inu 1x120 µg +1x0,5 ml susp. (liek.inj.skl.) |
MA Status: | E - Valid centralised marketing authorisation |
Type of procedure: | EU |
MAH, country: | GlaxoSmithKline Biologicals S.A., Belgium |
Shelf life: | 24 |
Container: | glass vial |
Route of admin.: | Intramuscular use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 06.06.2023 |
Validity: | 06.06.2028 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 19.06.2023 |